Beurs gesloten -
Hong Kong S.E.
10:08:06 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
38,25
HKD
|
-3,77%
|
|
+12,67%
|
-10,53%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
29.957
|
96.872
|
57.482
|
45.398
|
63.018
|
57.440
|
-
|
-
|
Bedrijfswaarde
1 |
26.589
|
89.793
|
50.957
|
39.338
|
63.018
|
52.609
|
53.141
|
52.657
|
K/w-verhouding
|
-16,3
x
|
-93,3
x
|
-18,2
x
|
-20,3
x
|
-
|
-68,5
x
|
348
x
|
40,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
0,01%
|
-
|
Marktkapitalisatie/omzet
|
28,6
x
|
25,2
x
|
13,5
x
|
9,96
x
|
10,2
x
|
7,59
x
|
5,82
x
|
4,41
x
|
Bedrijfswaarde/omzet
|
25,4
x
|
23,4
x
|
11,9
x
|
8,63
x
|
10,2
x
|
6,95
x
|
5,39
x
|
4,05
x
|
Bedrijfswaarde/EBITDA
|
-16,2
x
|
-370
x
|
-16,7
x
|
-14,3
x
|
-105
x
|
-108
x
|
103
x
|
27,3
x
|
Bedrijfswaarde/FCF
|
-13,1
x
|
-113
x
|
-16,5
x
|
-14
x
|
-
|
-56,5
x
|
-239
x
|
48,1
x
|
FCF Yield
|
-7,64%
|
-0,89%
|
-6,06%
|
-7,16%
|
-
|
-1,77%
|
-0,42%
|
2,08%
|
Price to Book
|
5,87
x
|
10,7
x
|
5,54
x
|
4,11
x
|
-
|
4,67
x
|
4,85
x
|
4,31
x
|
Aantal aandelen (in duizenden)
|
1.262.562
|
1.402.776
|
1.462.109
|
1.534.407
|
1.621.831
|
1.622.683
|
-
|
-
|
Referentieprijs
2 |
23,73
|
69,06
|
39,31
|
29,59
|
38,86
|
35,40
|
35,40
|
35,40
|
Datum van publicatie
|
30/03/20
|
29/03/21
|
29/03/22
|
28/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.048
|
3.844
|
4.270
|
4.556
|
6.206
|
7.565
|
9.863
|
13.012
|
EBITDA
1 |
-1.638
|
-242,4
|
-3.045
|
-2.747
|
-600,1
|
-485,5
|
516
|
1.931
|
Bedrijfsresultaat (EBIT)
1 |
-1.676
|
-310,4
|
-3.113
|
-3.066
|
-
|
-898,8
|
91,53
|
1.617
|
Operationele Marge
|
-159,96%
|
-8,08%
|
-72,9%
|
-67,29%
|
-
|
-11,88%
|
0,93%
|
12,43%
|
Resultaat voor belastingen (EBT)
1 |
-1.720
|
-858,7
|
-3.051
|
-2.170
|
-
|
-797,3
|
191,4
|
1.720
|
Nettowinst (verlies)
1 |
-1.720
|
-998,4
|
-3.138
|
-2.179
|
-
|
-825,4
|
129
|
1.436
|
Nettomarge
|
-164,2%
|
-25,97%
|
-73,5%
|
-47,83%
|
-
|
-10,91%
|
1,31%
|
11,04%
|
WPA
2 |
-1,460
|
-0,7400
|
-2,160
|
-1,460
|
-
|
-0,5164
|
0,1017
|
0,8835
|
Free Cash Flow
1 |
-2.030
|
-796,7
|
-3.090
|
-2.816
|
-
|
-931,9
|
-222,3
|
1.095
|
FCF-marge
|
-193,83%
|
-20,73%
|
-72,38%
|
-61,8%
|
-
|
-12,32%
|
-2,25%
|
8,42%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
56,72%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
76,25%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0,002500
|
-
|
Datum van publicatie
|
30/03/20
|
29/03/21
|
29/03/22
|
28/03/23
|
20/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Omzet
1 |
702
|
984,2
|
2.860
|
1.942
|
2.328
|
2.240
|
2.317
|
2.702
|
3.505
|
3.728
|
4.119
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-
|
-
|
-1.148
|
-1.960
|
-1.212
|
-1.617
|
-718,8
|
-
|
-692,6
|
-1.020
|
Operationele Marge
|
-
|
-
|
-
|
-59,12%
|
-84,17%
|
-54,11%
|
-69,8%
|
-26,61%
|
-
|
-18,58%
|
-24,77%
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-1.876
|
-998,9
|
-1.172
|
-256,1
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-
|
-
|
-
|
-
|
-1.963
|
-950,5
|
-1.229
|
-139,1
|
-
|
-
|
-
|
Nettomarge
|
-
|
-
|
-
|
-
|
-84,31%
|
-42,43%
|
-53,04%
|
-5,15%
|
-
|
-
|
-
|
WPA
2 |
-0,8400
|
-0,4600
|
-0,2800
|
-0,8100
|
-1,350
|
-0,6500
|
-0,8100
|
-0,0900
|
-
|
-0,3000
|
-0,5100
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/03/20
|
26/08/20
|
29/03/21
|
25/08/21
|
29/03/22
|
25/08/22
|
28/03/23
|
23/08/23
|
20/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
3.368
|
7.079
|
6.525
|
6.059
|
-
|
4.831
|
4.299
|
4.783
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2.030
|
-797
|
-3.090
|
-2.816
|
-
|
-932
|
-222
|
1.095
|
ROE (netto-inkomsten/eigen vermogen)
|
-38,4%
|
-14,8%
|
-32,8%
|
-20,7%
|
-
|
-6,59%
|
1%
|
9,86%
|
ROA (netto-inkomsten/totale activa)
|
-25,8%
|
-10,5%
|
-22,4%
|
-12,9%
|
-
|
-4,19%
|
0,6%
|
5,75%
|
Totale activa
1 |
6.672
|
9.533
|
14.039
|
16.916
|
-
|
19.687
|
21.445
|
24.968
|
Nettoactief per aandeel
2 |
4,040
|
6,470
|
7,100
|
7,200
|
-
|
7,580
|
7,300
|
8,210
|
Cashflow per aandeel
2 |
-1,410
|
-0,2300
|
-1,390
|
-1,290
|
-
|
-0,4100
|
0,1100
|
0,9600
|
Capex
1 |
366
|
489
|
1.066
|
897
|
-
|
701
|
733
|
776
|
Capex/omzet
|
34,93%
|
12,72%
|
24,96%
|
19,68%
|
-
|
9,27%
|
7,44%
|
5,97%
|
Datum van publicatie
|
30/03/20
|
29/03/21
|
29/03/22
|
28/03/23
|
20/03/24
|
-
|
-
|
-
|
Laatste slotkoers
35,4
CNY Gemiddelde koersdoel
51,17
CNY Spread / Gemiddelde doel +44,55% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,53% | 7,94 mld. | | -4,24% | 86,85 mld. | | +2,76% | 40,16 mld. | | -16,67% | 31,28 mld. | | +57,86% | 25,27 mld. | | -14,07% | 15,33 mld. | | -9,12% | 11,96 mld. | | -42,56% | 11,61 mld. | | +6,89% | 8,83 mld. | | +0,74% | 7,58 mld. |
Biofarmaceutica
|